Willis Investment Counsel
Source: SEC Form 13F · as of Mar 2026Willis Investment Counsel holds 16 biotech & pharma companies tracked by BioSniper, totaling $277.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$277.3M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 289,418 | $70.7M |
| PFEPFIZER INC | 1,717,937 | $48.2M |
| MRKMerck & Co., Inc. | 313,718 | $37.7M |
| DGXQuest Diagnostics Incorporated | 151,800 | $29.7M |
| SNYSanofi | 604,000 | $29.1M |
| ABTABBOTT LABORATORIES | 199,349 | $20.5M |
| ZTSZoetis Inc. | 139,959 | $16.5M |
| LLYELI LILLY & Co | 14,777 | $13.6M |
| MEDPMedpace Holdings Inc. | 10,114 | $4.9M |
| NRCNational Research Corporation Common Stock (Delaware) | 224,638 | $3.8M |
| TECHBIO-TECHNE Corp | 17,302 | $904K |
| MXCTMaxCyte Inc. | 862,758 | $606K |
| SUNSUNSET ISLAND GROUP | 4,883 | $317K |
| MCKMcKesson Corporation | 262 | $227K |
| ABBVAbbVie Inc. | 964 | $210K |
| SMMTSummit Therapeutics Inc. | 10,000 | $190K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.